EyePoint Pharmaceuticals
EYPT
#5227
Rank
NZ$2.55 B
Marketcap
NZ$30.85
Share price
0.45%
Change (1 day)
103.56%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Cash on Hand

Cash on Hand as of September 2025 : NZ$0.35 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company has NZ$0.35 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

EyePoint Pharmaceuticals - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.65 B25.64%
2023-12-31NZ$0.52 B129.91%
2022-12-31NZ$0.22 B-26.49%
2021-12-31NZ$0.30 B397.63%
2020-12-31NZ$62.24 M88.7%
2019-12-31NZ$32.98 M
2018-06-30NZ$57.25 M148.07%
2017-06-30NZ$23.08 M-43.19%
2016-06-30NZ$40.62 M-3.37%
2015-06-30NZ$42.04 M101.56%
2014-06-30NZ$20.85 M57.11%
2013-06-30NZ$13.27 M-26.88%
2012-06-30NZ$18.15 M-37.66%
2011-06-30NZ$29.12 M14.7%
2010-06-30NZ$25.39 M135.98%
2009-06-30NZ$10.76 M-47.55%
2008-06-30NZ$20.51 M490.75%
2007-06-30NZ$3.47 M-81.66%
2006-06-30NZ$18.93 M32.3%
2005-06-30NZ$14.31 M-57.98%
2004-06-30NZ$34.06 M2401.31%
2003-06-30NZ$1.36 M
2001-06-30NZ$4.04 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NRC Health
NRC
NZ$3.84 M-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
NZ$0.22 M-99.94% Bahamas